Overview

Providing safe and effective pain control can be achieved despite the serious public health crisis of the opioid overdose and misuse epidemic currently affecting the United States and other countries. This talk will review the evolution of the present-day opioid epidemic to better understand current risks. Terminology associated with addiction, currently referred to as substance use disorder, will be defined. Assessment of pain is imperative, with a shift away from intensity to functional ability. Risk factors for misuse must also be assessed. These findings inform the treatment regimen, including whether opioids are indicated, and if so, what mitigating strategies must be implicated to reduce the risk of misuse. Techniques such as harm reduction, weaning and safe handling will be addressed. 

Learning Objectives

  • Identify historical and other factors that contributed to the current opioid epidemic 
  • Define terms associated with pain and substance use disorder 
  • Review components of a thorough pain and risk assessment 
  • Integrate strategies to maintain patient safety, including safe storage and disposal, into clinical practice

 


Faculty

Judith A. Paice, PhD,RN

Director, Cancer Pain Program Division of Hematology-Oncology Northwestern University
Feinberg School of Medicine Chicago, IL

Disclosures

The following relevant financial relationships have been disclosed by faculty: 

Judith A Paice, PhD, RN 

Advisory Board member for Novo Nordisk. Contracted Research for Novo Nordisk. 

 

Non-faculty contributors involved in the planning, development, editing, and review of the content have disclosed no relevant financial relationships.

Commercial Supporter

Not Applicable

Education Partner

Not Applicable


CME/CE Information

AMA PRA Category 1 Credits

Accreditation Statement

pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Designation Statement

pmiCME designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For APRNs and PAs, AANPCB and NCCPA accept AMA PRA Category 1 Creditâ„¢ as the number of hours of participation (AANPCB) or as Category 1 CME credits (NCCPA).

Fine Print

Internet Explorer (version 9.0 and above) is the minimum supported browser for Pri-Med Online eCME activities. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection (DSL, cable modem, or LAN-based) is not required; however, it is recommended for faster download times.

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, pmiCME, pmiCME Advisory Boards and Consultants, DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

pmiCME educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of pmiCME to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.

pmiCME Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. pmiCME, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. pmiCME is the accredited provider for this activity.

Disclosures and Conflict of Interest
pmiCME requires all individuals in a position to influence educational content for pmiCME-certified CME/CE activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. pmiCME assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by pmiCME or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.